Macdougall I.C. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl 69 (1999) S61-S66
Afzali B., and Goldsmith D.J. Intravenous iron treatment in renal failure: friend and foe?. J Nephrol 17 (2004) 487-495
Macdougall I., Bailie G., Richardson D., et al. Worldwide safety profile of iron sucrose injection (Venofer) analysis of 1,004,477 patients from 1992 to 2001. J Am Soc Nephrol 12 (2001) 333A
Cavill I. Intravenous iron as adjuvant treatment: a two-edged sword?. Nephrol Dial Transplant 18 Suppl 8 (2003) viii24-viii28
Mamula P., Piccoli D., Susan P., et al. Total dose intravenous infusion of iron dextran for iron-deficiency anaemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 34 (2002) 286-290
Hickman M.A., Bernstein I.L., and Palascak J.E. Successful administration of iron dextran in a patient who experienced a life threatening reaction to intravenous iron dextran. Ann Allergy Asthma Immunol 84 (2000) 262-263
Rutgeerts P., Van Assche G., and Vermeire S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 126 (2004) 1593-1610
Rutgeerts P., Feagan B.C., Lichtenstein G.R., et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 126 (2004) 598-601
Rutgeerts P. Efficacy of infliximab in Crohn's disease-induction and systematic of remission. Aliment Pharmacol Ther 13 (1999) 9-15
Van Assche G., Vermeire S., and Rutgeerts P. Medical treatment of inflammatory bowel diseases. Curr Opin Gastroenterol 21 (2005) 443-447
Demirturk L., Hulagu S., Yaylaci M., et al. Serum erythropoietin levels in patients with severe anaemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin inpatients with anaemia refractory to treatment. Dis Colon Rectum 38 (1995) 896-897
Kapsoritakis A.N., Koukourakis M.I., Sfiridaki A., et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96 (2001) 776-781
Tsitsika A., Stamoulakatou A., Kafritsa Y., et al. Erythropoietin levels in children and adolescents with inflammatory bowel disease. J Pediatr Hematol Oncol 27 (2005) 93-96
Schreiber S., Howaldt S., Schnoor M., et al. Recombinant erythropoietin for the treatment of anaemia in inflammatory bowel disease. N Engl J Med 334 (1996) 619-623
Gasche C., Waldhoer T., Feichtenschlager T., et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anaemia. Am J Gastroenterol 96 (2001) 2382-2387
Roy C.N., Weinstein D.A., and Andrews N.C. 2002 E. Mead Johnson award for research in pediatrics lecture: the molecular biology of the anaemia of chronic disease: a hypothesis. Pediatr Res 53 (2003) 507-512
Oldenburg B., Koningsberger J.C., Van Berge Henegouwen G.P., et al. Iron and inflammatory bowel disease. Aliment Pharmacol Ther 15 (2001) 429-438
Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 329 (2003) 9-22
Feelders R.A., Kuiper-Kramer E.P., and van Eijk H.G. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med 37 (1999) 1-10
Ferrante M., Pierik M., Henckaerts L., et al. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 870-878
Gasche C., Reinisch W., Lochs H., et al. Anaemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 39 (1994) 1930-1934
Gasche C., Lomer M.C.E., Cavill I., et al. Iron, anaemia, and inflammatory bowel diseases. Gut 53 (2004) 1190-1197
Gasche C., Dejaco C., Waldhoer T., et al. Intravenous iron and erythropoietin for anaemia associated with Crohn disease. Ann Intern Med 126 (1997) 782-787
Gasche C., Dejaco C., Reinisch W., et al. Sequential treatment of anaemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 60 (1999) 262-267
Erichsen K., Ulvik R.J., Nysaeter G., et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 40 (2005) 1058-1065
Bodemar G., Kechagias S., Almer S., et al. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand J Gastroenterol 39 (2004) 454-458
Jelkmann W., and Wiedemann G. Lack of sex dependence of the serum level of immunoreactive erythropoietin in chronic anaemia. Klin Wochenschr 67 (1989) 1218
Goldgerg M.A., and Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269 (1994) 4355-4359
Johanssen H., Jelkmann W., Wiedemann G., et al. Erythropoietin/haemoglobin relationship in leukemia and ulcerative colitis. Eur J Haematol 43 (1989) 201-206
Kokot F., Grzeszczak W., Wiecek A., et al. Plasma erythropoietin levels in patients with stabilized function of the transplanted kidney. Pol Arch Med Wewn 85 (1991) 365-372
Montanaro D., Gropuzzo M., Tulissi P., et al. Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant receipients. Transplant Proc 33 (2001) 3253-3255
Jensen J.D., Hansen H.E., and Pedersen E.B. Increased serum erythropoietin level during azathioprine treatment in renal transplant recipients. Nephron 67 (1994) 297-301
Howarth J.E., Waters H.M., Shanks D., et al. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin. J Clin Pathol 46 (1993) 41-44
Wolff M., and Jelkmann W. Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures. Ann Hematol 66 (1993) 27-31
Koutroubakis I.E., Karmiris K., Makreas S., Xidakis C., Niniraki M., and Kouroumalis E.A. Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study. Eur J Gastroenterol Hepatol 18 (2006) 421-425
Papadaki H.A., Kritikos H.D., Gementzi C., et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood 99 (2002) 1610-1619
Domenech E., Manosa M., Masnou H., et al. Infliximab for the treatment of chronic anaemia in Crohn's disease. Am J Gastroenterol 100 (2005) 496
Stasi R., and Amadori S. Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes. Br J Haematol 116 (2002) 334-337
Tam B.Y.Y., Wei K., Rudge J.S., et al. VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med 12 (2006) 793-800
Picaud J.C., Putet G., Salle B.L., et al. Supplementation en fer chez les enfants prematures traits par erythropoietine. Arch Pediatr 6 (1999) 657-664
Charytan C., Levin N., Al-Saloum M., et al. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis associated anaemia: North American clinical trial. Am J Kidney Dis 37 (2001) 300-307
Fishbane S., Ungureanu V.D., Maesaka J.K., et al. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 28 (1996) 529-534
Stoves J., Inglis H., and Newstead C.G. A randomized study of oral vs. intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. Nephrol Dial Transplant 16 (2001) 967-974
Schroder O., Mickisch O., Seidler U., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease-a randomized, controlled open-label, multicenter study. Am J Gastroenterol 100 (2005) 2503-2509
Feldman H.I., Santanna J., Guo W., et al. Iron administration and clinical outcomes in hemodialysis patients. J Am Soc Nephrol 13 (2002) 734-744
Gasche C. Anaemia in IBD: the overlooked villain. Inflamm Bowel Dis 6 (2000) 142-150
Wilson A., Reyes E., and Ofman J. Prevalence and outcomes of anaemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 116 7A (2004) 44S-49S
Kahraman S., Yilmaz R., Genctoy G., et al. Efficacy and safety of intravenous iron treatment for HCV-positive haemodialysis patients. Nephrol Clin Pract 100 (2005) c78-c85
Christodoulou D.K., and Tsianos E.V. Anaemia in inflammatory bowel disease-the role of recombinant human erythropoietin. Eur J Intern Med 11 (2000) 222-227
Thayu M., and Mamula P. Treatment of iron deficiency anaemia in pediatric inflammatory bowel disease. Curr Treat Options Gastroenterol 8 (2005) 411-417
